Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KE.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
KE.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KE.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KE.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KE.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
KE.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HF.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HF.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HF.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HF.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HF.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HF.1.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HK.22ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HK.22ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HK.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HK.22NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FW.1.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FW.1.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FW.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FW.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FW.1.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FW.1.1.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.13ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.13ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.13NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.13NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KH.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
KH.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KH.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KH.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KH.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KH.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
LM.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
LM.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
LM.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LM.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LM.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LM.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.1.17ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.17ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.17NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.17NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.15ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.15ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used